The FDA on Monday said it’s entering into a collaboration with the nonprofit group PATH “to speed creation of a pneumococcal vaccine for children in developing nations,” United Press International reports (2/1).
Pneumonia & Flu
The Canadian government on Thursday announced the country would donate five million doses of H1N1 vaccines to the WHO from the country’s current surplus, the Canadian Press reports (Branswell, 1/28). “[T]he donation will help the Geneva-based international body in its efforts to redistribute the vaccine to developing countries that couldn’t afford their own supplies,” the Globe and Mail reports (Alphonso, 1/28).
Biovac Institute, a South African vaccine maker, said Monday that it is working with other major pharmaceutical firms to increase its annual capacity sevenfold to 35 million doses by 2013, Reuters reports. Morena Makhoana, the company’s deputy chief executive, said that 25 million of those doses will remain in Africa.
During a Council of Europe meeting on Tuesday to address the WHO’s handling of the H1N1 virus, the WHO said it had not “fallen under the sway of drugs firms and exaggerated the dangers of the H1N1 flu virus, but said it might have handled the crisis better,” Reuters reports. “Critics say the WHO relied too much on advice from advisers in the pay of the pharmaceutical industry, triggering an internal review by the WHO and an inquiry by the Council of Europe, a pan European human rights watchdog,” writes the news service (Reilhac, 1/26).
ICRC AppealsÂ For Attention To Yemen’s Growing Humanitarian Crisis The International Committee of the Red Cross (ICRC) on Monday appealed to countries participating in an international conference on Yemen’s threat to global security this week in London to also discuss the deepening humanitarian crisis the country is facing, the Associated Press/Taiwan…
During the WHO’s recent executive board meeting, WHO Director-General Margaret Chan reflected on public health gains over the past decade and the challenges that lie ahead, Nigeria’s Guardian reports. Chan commended the international community’s response to H1N1 and global efforts to reduce child mortality, fight malaria and tuberculosis.
WHO spokesperson Gregory Hartl on Monday rejected accusations that the organization miscategorized H1N1 (swine flu) as a pandemic, calling such accusations “irresponsible,” the Associated Press/Washington Post reports. “WHO also dismissed claims it colluded with drug companies to bring economic benefit to the industry by playing up the danger of the new H1N1 [swine flu] influenza strain,” the news service writes.
Long-Term Rebuilding Strategy ‘Vital’ To Haiti An Economist editorial examines the relief and recovery efforts in Haiti and theÂ “vital” importance of planning for rebuilding the country “before the worldâ€™s generosity turns to cynicism. Fortunately there is a blueprint, drawn up by Haitiâ€™s government and presented to donors last year. It…
Though H1N1 (swine flu) activity worldwide has slowed, the potential of a new wave of infections in the northern hemisphere in late winter or early spring remains viable, Keiji Fukuda, the WHO’s top flu expert, said Monday at the start of the WHO’s weeklong Executive Board meeting, Reuters reports. The H1N1 pandemic “initially sparked widespread concern about antiviral and vaccine supplies, especially in developing countries, but many nations have cut back their vaccine orders recently because the pandemic has not turned out as deadly as originally feared,” the news service writes (Nebehay, 1/18).
Lancet Series Papers Examine Surveillance, Economic Impact Of NTDs “As national programmes respond to the new opportunities presented for scaling up preventive chemotherapy programmes for the coadministration of drugs to target [several neglected tropical diseases (NTDs)] possible synergies between existing disease-specific policies and protocols need to be examined,” write the…